An official website of the United States government
EGRP Cancer Epidemiology News
April 2024
- Supporting Digital Health Technologies in Cancer Research
- Funding Opportunities
- Grants Policy Announcements
- Requests for Information
- Training Opportunities
- Research Resources
- News and Blog Posts
Supporting Digital Health Technologies in Cancer Research
Digital health is a multidisciplinary field that encompasses many domains, including health IT, mobile health, wearable devices, telehealth, personalized medicine, and the data infrastructure and ecosystem to enable integration and analysis of data from these technologies. Digital health approaches can significantly advance the assessment, monitoring, and understanding of cancer risk factors and determinants and increase participant reach and engagement in cancer research.
NCI’s Division of Cancer Control and Population Sciences (DCCPS) and the Epidemiology and Genomics Research Program’s (EGRP) Risk Factor Assessment Branch lead several digital health-related funding opportunity announcements with other NIH and federal partners. Active notices of funding opportunities include:
- NIH-NSF Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (see NOT-OD-23-165, NSF 23-614)
- Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research (see NOT-CA-23-037)
- NOSI: Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research (see NOT-CA-24-031)
Digital health plays a pivotal role in the future of cancer control research, enabling integration, analysis, and interpretation of patient data. It is important to understand how digital health approaches can advance the assessment, monitoring, and understanding of multilevel cancer risk factors and determinants; increase participant reach and engagement in clinical, behavioral, and epidemiological cancer research; and improve the delivery of cancer-related care.
DCCPS staff and others from NCI are also participating in CancerX
, a public-private partnership announced as part of the reignited Cancer MoonshotSM in February 2023 to boost innovation in the fight against cancer. With a mission to identify, support, grow, and implement world-class digital solutions to reduce the burden of cancer for all people, CancerX aligns with the goals set forth in the National Cancer Plan and the DCCPS mission. The inaugural project is developing evidence, best practices, and a toolkit focused on improving equity and reducing financial toxicity in cancer care and research through digital health technologies. Building on this work, CancerX recently launched a demonstration project that will combine the implementation and evaluation of a digitally enabled cancer care model with the development of an associated alternative payment model to combine clinical decision support, virtual-first care, and navigation programs at scale to improve patient access and reduce financial toxicity.
Stay up to date on future opportunities by bookmarking EGRP’s digital health technologies for cancer research web page. For questions, contact Dana Wolff-Hughes, Ph.D.
Funding Opportunities
- OTA-24-095, Advancing Health Research through Ethical, Multimodal AI
- RFA-CA-24-020, Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54, Clinical Trial Optional)
- Note: NCI is holding a pre-application webinar for RFA-CA-24-020 on May 7, 2024, from 1:30-3:00 PM ET. View details in NOT-CA-24-043.
- RFA-RM-24-006, Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03, Clinical Trial Not Allowed)
- RFA-RM-24-002, NIH Director's Pioneer Award Program (DP1, Clinical Trial Optional)
- RFA-RM-24-003, NIH Director's New Innovator Award Program (DP2, Clinical Trial Optional)
- RFA-RM-24-004, NIH Director's Transformative Research Awards (R01, Clinical Trial Optional)
- RFA-RM-24-005, NIH Director's Early Independence Awards (DP5, Clinical Trial Optional)
- PAR-24-110, Interventions to Reduce Sleep Health Disparities (R01, Clinical Trial Optional)
- PAR-24-153, The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12, Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans
- PAR-24-160 (R01, Clinical Trial Optional)
- PAR-24-161 (R21, Clinical Trial Optional)
- NOT-CA-24-041, Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care
- NOT-CA-24-044, NOSI: Administrative Supplements for the Study of the Diverse Aspects of Uterine Serous Carcinoma (Clinical Trial Not Allowed)
- NOT-CA-24-039, NOSI: Administrative Supplements for NCI Center for Global Health Research Programs
- NOT-OD-24-078, NOSI: Supporting the Exploration of Cloud in NIH-supported Research
- NOT-OD-24-079, NOSI: Women’s Health Research
Grants Policy Announcements
- NOT-OD-24-105, “NIH Grants Process: A Brief Walk-Through for Beginners” – Registration Open for May 15, 2024 Webinar
- NOT-OD-24-099, Notice to Extend Parent R01/R03/R21 Parent Notices of Funding Opportunities
- NOT-OD-24-084, Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025
- NOT-OD-24-085, Simplified Review Framework for NIH Research Project Grant Applications – Update and Implementation Plans
- NOT-OD-24-086, New NIH “FORMS-I” Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2025
- NOT-OD-24-107, Implementation of Revisions to the NIH and AHRQ Fellowship Application and Review Process
Requests for Information
- NOT-OD-24-063, RFI: Proposed Use of Common Data Elements for NIH-Funded Clinical Research and Trials (response date extended to May 7, 2024)
- NOT-OD-24-088, RFI on potential strategic priorities for the NIH Environmental influences on Child Health Outcomes (ECHO) Program through 2029 (responses requested by May 31, 2024)
Training Opportunities
- NOT-OD-24-103, NIH Entrepreneurship Boot Camp for pre-SBIR/STTR Innovators
Research Resources
- Updated SEER Data and Statistics
- Updated Cancer Trends Progress Report
- 2024 version of Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) Now Available
News and Blog Posts
- Fiscal Year 2024 Appropriation Brings Clarity and Difficult Choices
- Changes Coming to Applications and Peer Review in January 2025
- Studies Assess Impact of Cancer Risk-Reduction Measures for People with BRCA Changes
- Microbe Normally Found in the Mouth May Drive Progression of Colorectal Cancer
- Drug Combination May Have Potential for Cancers with TP53 Mutations
- Stress-Induced Immune Changes May Help Cancer Spread
- Simple Hysterectomy May Expand Treatment Options for Early-Stage Cervical Cancer
- From Awareness to Action: Putting Cancer Disparities in the Rearview Mirror
Stay Connected
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730